The Use of Clinical Data to Inform and Identify the Potential New Value of Existing HDTs

P Speaker(s)

• 

  Heather Stone, MPH (she/her/hers)

  Health Science Policy Analyst
  US Food & Drug Administration
  Silver Spring, Maryland, United States